Canada Post Xpresspost within Canada: $25.00 flat rate; free on product subtotals of $299.00 or more · Interac e-Transfer

BlueNex Labs

Research · 2025-09-21

Scientific lead: Alice Kay, Ph.D.

What is Thymosin Alpha-1? Immune-model note

Direct answer

Thymosin alpha-1 is a 28-residue thymic peptide discussed in T-cell and innate-immune signalling models. It is not the TB-500 thymosin beta-4 fragment.

Scope

Tissue, matrix & repair models. BPC-157, GHK-Cu, TB-500, and related matrix or cell-migration papers. Educational overviews, not product listings.

Reviewer: Alice Kay, Ph.D., scientific lead. This note does not claim that the reviewer authored any cited paper.

Thymosin Alpha-1 Research Overview

Thymosin alpha-1 is a 28-residue thymic peptide discussed in T-cell and innate-immune signaling models. It is a different sequence from the TB-500 thymosin beta-4 fragment.

This page provides laboratory-focused information for Thymosin Alpha-1. Content is intended for research use only and should be read with the published documentation and analytical data.

Thymosin Alpha-1 research peptide vial label for laboratory peptide research

> Research-use notice: This article is educational laboratory context only. It is not medical advice. No dosing, administration, or human-use guidance is provided. BlueNex Labs research-use-only products are not intended for human or veterinary use.

Thymosin alpha-1 is a 28-residue peptide originally described in thymosin fraction 5, a thymic extract. Research groups use the defined synthetic sequence to study immune-cell signalling. This page is a research guide. Purchase intent belongs on the Thymosin Alpha-1 10 mg product page.

Structure

Published descriptions treat thymosin alpha-1 as a longer thymic peptide than the fragments sold under other names:

  • About 28 amino acids, with an acetylated N-terminus in the sequence used in most laboratory papers

  • A distinct primary structure from thymosin beta-4 and from TB-500, which is modelled on an actin-binding motif of thymosin beta-4

  • Lyophilized research fills whose identity is confirmed by mass spectrometry when a Certificate of Analysis is published

  • No basis for borrowing a TB-500 or blend certificate to document this vial

The lot report, not this article, is the identity record for a specific fill.

Mechanisms discussed in research settings

Literature commonly places thymosin alpha-1 in:

  • T-cell differentiation and maturation markers in culture

  • Innate-immune pathway mapping, including Toll-like receptor assays

  • Comparative work against other thymic peptides that do not share this sequence

  • Aging-biology discussions of immune-cell signalling, which the longevity roundup only summarizes

Results are model-specific. This article does not translate those models into personal-use claims.

Cluster navigation

RUO

Research use only. Not for human or veterinary use. No administration guidance is provided.

References

This note does not add a separate citation list. Named papers, when the body links them, stay in the text above.

Research use only. BlueNex Labs does not provide medical or veterinary advice. Confirm your institution’s policies before purchase. Lot-file rules for this note are on the documentation standards page. Scientific lead: Alice Kay, Ph.D.